• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用工程化 RNA 二级结构提高 CRISPR 系统的特异性。

Increasing the specificity of CRISPR systems with engineered RNA secondary structures.

机构信息

Department of Biomedical Engineering, Duke University, Durham, NC, USA.

Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.

出版信息

Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15.

DOI:10.1038/s41587-019-0095-1
PMID:30988504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6626619/
Abstract

CRISPR (clustered regularly interspaced short palindromic repeat) systems have been broadly adopted for basic science, biotechnology, and gene and cell therapy. In some cases, these bacterial nucleases have demonstrated off-target activity. This creates a potential hazard for therapeutic applications and could confound results in biological research. Therefore, improving the precision of these nucleases is of broad interest. Here we show that engineering a hairpin secondary structure onto the spacer region of single guide RNAs (hp-sgRNAs) can increase specificity by several orders of magnitude when combined with various CRISPR effectors. We first demonstrate that designed hp-sgRNAs can tune the activity of a transactivator based on Cas9 from Streptococcus pyogenes (SpCas9). We then show that hp-sgRNAs increase the specificity of gene editing using five different Cas9 or Cas12a variants. Our results demonstrate that RNA secondary structure is a fundamental parameter that can tune the activity of diverse CRISPR systems.

摘要

CRISPR(成簇规律间隔短回文重复)系统已广泛应用于基础科学、生物技术、基因和细胞治疗。在某些情况下,这些细菌核酸酶表现出脱靶活性。这给治疗应用带来了潜在的危险,并可能混淆生物研究的结果。因此,提高这些核酸酶的精度是人们广泛关注的问题。在这里,我们展示了在单引导 RNA(sgRNA)的间隔区构建发夹二级结构(hp-sgRNA)可以与各种 CRISPR 效应物结合,将特异性提高几个数量级。我们首先证明,设计的 hp-sgRNA 可以调节基于化脓性链球菌 Cas9 的转录激活因子(SpCas9)的活性。然后我们表明,hp-sgRNA 提高了使用五种不同 Cas9 或 Cas12a 变体进行基因编辑的特异性。我们的结果表明,RNA 二级结构是一个可以调节不同 CRISPR 系统活性的基本参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/b1e33f61e67b/nihms-1523757-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/245caf97c52c/nihms-1523757-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/a4481621bab5/nihms-1523757-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/aa5f9e315a48/nihms-1523757-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/cceda4998ed6/nihms-1523757-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/981c779362b8/nihms-1523757-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/b1e33f61e67b/nihms-1523757-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/245caf97c52c/nihms-1523757-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/a4481621bab5/nihms-1523757-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/aa5f9e315a48/nihms-1523757-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/cceda4998ed6/nihms-1523757-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/981c779362b8/nihms-1523757-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f56/6626619/b1e33f61e67b/nihms-1523757-f0006.jpg

相似文献

1
Increasing the specificity of CRISPR systems with engineered RNA secondary structures.利用工程化 RNA 二级结构提高 CRISPR 系统的特异性。
Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15.
2
Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.使用包含 PAM 改变的 Cas9 变体和 gRNA 的改良 CRISPR/Cas9 工具包在拟南芥中开发可遗传突变。
Plant Cell Physiol. 2019 Oct 1;60(10):2255-2262. doi: 10.1093/pcp/pcz118.
3
Engineering guide RNA to reduce the off-target effects of CRISPR.工程化引导 RNA 以减少 CRISPR 的脱靶效应。
J Genet Genomics. 2019 Nov 20;46(11):523-529. doi: 10.1016/j.jgg.2019.11.003. Epub 2019 Nov 23.
4
Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.SaCas9 与 SpCas9 在基因组编辑中的高保真度和明显的编辑效果比较。
Genomics Proteomics Bioinformatics. 2023 Dec;21(6):1206-1220. doi: 10.1016/j.gpb.2022.12.003. Epub 2022 Dec 20.
5
A highly specific SpCas9 variant is identified by in vivo screening in yeast.在酵母体内筛选出一种高度特异性的 SpCas9 变体。
Nat Biotechnol. 2018 Mar;36(3):265-271. doi: 10.1038/nbt.4066. Epub 2018 Jan 29.
6
Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.理性设计的 CRISPR-Cas9 的抗 CRISPR 核酸抑制剂。
Nucleic Acid Ther. 2019 Jun;29(3):136-147. doi: 10.1089/nat.2018.0758. Epub 2019 Apr 16.
7
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.具有不可检测的全基因组脱靶效应的高保真CRISPR-Cas9核酸酶。
Nature. 2016 Jan 28;529(7587):490-5. doi: 10.1038/nature16526. Epub 2016 Jan 6.
8
Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.利用马铃薯 X 病毒载体中非间隔 sgRNA 阵列工程实现高效 Cas9 多重编辑。
Plant J. 2021 Apr;106(2):555-565. doi: 10.1111/tpj.15164. Epub 2021 Mar 10.
9
Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity.将桥连核酸整合到 CRISPR RNA 中可提高 Cas9 内切酶的特异性。
Nat Commun. 2018 Apr 13;9(1):1448. doi: 10.1038/s41467-018-03927-0.
10
Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.编辑删节:CRISPR RNA 引导的核酸酶 Cas9 和 Cas12a 对 DNA 的切割。
Biochem Soc Trans. 2020 Feb 28;48(1):207-219. doi: 10.1042/BST20190563.

引用本文的文献

1
The Interface of Gene Editing with Regenerative Medicine.基因编辑与再生医学的界面
Engineering (Beijing). 2025 Mar;46:73-100. doi: 10.1016/j.eng.2024.10.019. Epub 2024 Nov 30.
2
Validation of caprine H11 and the Rosa26 platform for transgene integration via CRISPR-based system: investigations on stable transgene expression and genetic biosafety.基于CRISPR系统的转基因整合中羊H11和Rosa26平台的验证:稳定转基因表达及遗传生物安全性研究
Funct Integr Genomics. 2025 Aug 29;25(1):180. doi: 10.1007/s10142-025-01679-x.
3
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease.

本文引用的文献

1
CasX enzymes comprise a distinct family of RNA-guided genome editors.CasX 酶构成了一个独特的 RNA 引导的基因组编辑酶家族。
Nature. 2019 Feb;566(7743):218-223. doi: 10.1038/s41586-019-0908-x. Epub 2019 Feb 4.
2
Functionally diverse type V CRISPR-Cas systems.功能多样的 V 型 CRISPR-Cas 系统。
Science. 2019 Jan 4;363(6422):88-91. doi: 10.1126/science.aav7271. Epub 2018 Dec 6.
3
Minimal PAM specificity of a highly similar SpCas9 ortholog.高度相似的 SpCas9 同源物的最小 PAM 特异性。
用于中枢神经系统疾病的腺相关病毒介导的基因编辑疗法的趋势与挑战:对神经退行性疾病的启示
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102635. doi: 10.1016/j.omtn.2025.102635. eCollection 2025 Sep 9.
4
CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein-Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells.CRISPR/Cas13介导的EBNA1抑制对鼻咽癌细胞中EB病毒转录本和DNA载量的抑制作用
Viruses. 2025 Jun 26;17(7):899. doi: 10.3390/v17070899.
5
Directed evolution expands CRISPR-Cas12a genome-editing capacity.定向进化扩展了CRISPR-Cas12a基因组编辑能力。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf649.
6
TOP-SECRETS enables Cas9 nucleases to discriminate SNVs outside of PAMs.TOP-SECRETS使Cas9核酸酶能够区分PAM之外的单核苷酸变异。
bioRxiv. 2025 May 10:2025.05.06.652491. doi: 10.1101/2025.05.06.652491.
7
Systematic high-throughput evaluation reveals FrCas9's superior specificity and efficiency for therapeutic genome editing.系统的高通量评估揭示了FrCas9在治疗性基因组编辑方面具有卓越的特异性和效率。
Sci Adv. 2025 Mar 28;11(13):eadu7334. doi: 10.1126/sciadv.adu7334. Epub 2025 Mar 26.
8
Emerging applications of gene editing technologies for the development of climate-resilient crops.基因编辑技术在培育气候适应型作物方面的新兴应用。
Front Genome Ed. 2025 Mar 10;7:1524767. doi: 10.3389/fgeed.2025.1524767. eCollection 2025.
9
Recent advances in therapeutic gene-editing technologies.治疗性基因编辑技术的最新进展。
Mol Ther. 2025 Jun 4;33(6):2619-2644. doi: 10.1016/j.ymthe.2025.03.026. Epub 2025 Mar 20.
10
A Study of CRISPR Ribonucleoprotein Displacement in Cell-Free Systems.无细胞系统中CRISPR核糖核蛋白置换的研究
ACS Omega. 2025 Feb 26;10(9):9154-9164. doi: 10.1021/acsomega.4c09275. eCollection 2025 Mar 11.
Sci Adv. 2018 Oct 24;4(10):eaau0766. doi: 10.1126/sciadv.aau0766. eCollection 2018 Oct.
4
Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.利用 CIRCLE-seq 定义 CRISPR-Cas9 全基因组核酸酶活性。
Nat Protoc. 2018 Nov;13(11):2615-2642. doi: 10.1038/s41596-018-0055-0.
5
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.通过微型 CRISPR-Cas14 酶实现程序化 DNA 破坏。
Science. 2018 Nov 16;362(6416):839-842. doi: 10.1126/science.aav4294. Epub 2018 Oct 18.
6
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.一种高保真 Cas9 突变体作为核糖核蛋白复合物递送至体内,可实现人类造血干细胞和祖细胞中的高效基因编辑。
Nat Med. 2018 Aug;24(8):1216-1224. doi: 10.1038/s41591-018-0137-0. Epub 2018 Aug 6.
7
Directed evolution of CRISPR-Cas9 to increase its specificity.定向进化 CRISPR-Cas9 以提高其特异性。
Nat Commun. 2018 Aug 6;9(1):3048. doi: 10.1038/s41467-018-05477-x.
8
Chimeric Guides Probe and Enhance Cas9 Biochemical Activity.嵌合向导探针可探测并增强Cas9的生化活性。
Biochemistry. 2018 May 29;57(21):3027-3031. doi: 10.1021/acs.biochem.8b00107. Epub 2018 May 14.
9
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.利用 RNA 靶向的 VI-D CRISPR 效应蛋白进行转录组工程
Cell. 2018 Apr 19;173(3):665-676.e14. doi: 10.1016/j.cell.2018.02.033. Epub 2018 Mar 15.
10
A highly specific SpCas9 variant is identified by in vivo screening in yeast.在酵母体内筛选出一种高度特异性的 SpCas9 变体。
Nat Biotechnol. 2018 Mar;36(3):265-271. doi: 10.1038/nbt.4066. Epub 2018 Jan 29.